Market Recap Check: Ginkgo Bioworks Holdings Inc (DNA)’s Positive Finish at 11.36, Up/Down 0.98

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

The price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $11.36 in the last session, up 0.98% from day before closing price of $11.25. In other words, the price has increased by $0.98 from its previous closing price. On the day, 1.91 million shares were traded. DNA stock price reached its highest trading level at $11.73 during the session, while it also had its lowest trading level at $10.55.

Ratios:

We take a closer look at DNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.

Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 23 ’25 when Che Austin bought 99 shares for $8.43 per share.

Che Austin bought 99 shares of DNA for $857 on Jun 20 ’25. On Jun 18 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $8.46 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 664922368 and an Enterprise Value of 576122624. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.80 while its Price-to-Book (P/B) ratio in mrq is 0.91. Its current Enterprise Value per Revenue stands at 2.427 whereas that against EBITDA is -1.772.

Stock Price History:

The Beta on a monthly basis for DNA is 1.49, which has changed by -0.24468082 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $16.85, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is 41.34%, while the 200-Day Moving Average is calculated to be 29.94%.

Shares Statistics:

According to the various share statistics, DNA traded on average about 1.34M shares per day over the past 3-months and 1911000 shares per day over the past 10 days. A total of 43.08M shares are outstanding, with a floating share count of 38.16M. Insiders hold about 31.28% of the company’s shares, while institutions hold 57.97% stake in the company. Shares short for DNA as of 1749772800 were 11312529 with a Short Ratio of 8.46, compared to 1747267200 on 11493376. Therefore, it implies a Short% of Shares Outstanding of 11312529 and a Short% of Float of 25.069999999999997.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.